Submitted by Anonymous (not verified) on 4 September 2023 - 10:40
Human medicines European public assessment report (EPAR): Revinty Ellipta, fluticasone furoate,vilanterol, Asthma, Date of authorisation: 02/05/2014, Revision: 22, Status: Authorised
Source: